Amyloid-beta peptide induces temporal membrane biphasic changes in astrocytes through cytosolic phospholipase A2.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2008-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbamem.2008.07.027PMID 18725190PMCID PMC2592609
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Author ' s personal copy

  2009cited by this paper
• Intracellular phospholipase A2 expression and location in human macrophages: Influence of synthetic material surface chemistry

  2008cited by this paper
• Alterations of some membrane transport proteins in Alzheimer's disease: role of amyloid beta-peptide.

  2008cited by this paper
• The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer’s disease

  2007cited by this paper
• Autoinsertion of soluble oligomers of Alzheimer's Aβ(1–42) peptide into cholesterol-containing membranes is accompanied by relocation of the sterol towards the bilayer surface

  2006cited by this paper
• DOCOSAHEXAENOIC ACID‐INDUCED PROTECTIVE EFFECT AGAINST IMPAIRED LEARNING IN AMYLOID β‐INFUSED RATS IS ASSOCIATED WITH INCREASED SYNAPTOSOMAL MEMBRANE FLUIDITY

  2006cited by this paper
• Phospholipase A₂-Generated Lipid Mediators in the Brain: The Good, the Bad, and the Ugly

  2006cited by this paper
• The ups and downs of Abeta.

  2006cited by this paper
• The role of cytosolic phospholipase A2-alfa in regulation of phagocytic functions.

  2006cited by this paper
• The ups and downs of Aβ

  2006cited by this paper
• Phospholipases A2 Mediate Amyloid-β Peptide-Induced Mitochondrial Dysfunction

  2006cited by this paper
• Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly.

  2006cited by this paper
• Stimulation of NADPH oxidase by angiotensin II in human neutrophils is mediated by ERK, p38 MAP-kinase and cytosolic phospholipase A2

  2005cited by this paper
• Cyclic mechanical strain increases reactive oxygen species production in pulmonary epithelial cells.

  2005cited by this paper
• Hydrogen peroxide alters membrane and cytoskeleton properties and increases intercellular connections in astrocytes

  2005cited by this paper
• Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦

  2005cited by this paper
• Expression and Modulation of an NADPH Oxidase in Mammalian Astrocytes

  2005cited by this paper
• Inhibition of phospholipase A2 activity reduces membrane fluidity in rat hippocampus

  2005cited by this paper
• β-Amyloid Peptides Induce Mitochondrial Dysfunction and Oxidative Stress in Astrocytes and Death of Neurons through Activation of NADPH Oxidase

  2004cited by this paper
• Visualizing lipid structure and raft domains in living cells with two-photon microscopy

  2003influential reference
• Nutrition and Biochemistry of Phospholipids

  2003cited by this paper
• Peroxisomal Disorders and Regulation of Genes

  2003cited by this paper
• Unique targeting of cytosolic phospholipase A2 to plasma membranes mediated by the NADPH oxidase in phagocytes

  2003cited by this paper
• Plasmalogens, docosahexaenoic acid and neurological disorders.

  2003cited by this paper
• Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease.

  2003cited by this paper
• Stimulation of Lipases and Phospholipases in Alzheimer Disease

  2003cited by this paper
• Cytosolic Phospholipase A2 (cPLA2) Regulation of Human Monocyte NADPH Oxidase Activity

  2002cited by this paper
• Aβ42-Peptide Assembly on Lipid Bilayers

  2002cited by this paper
• Phospholipase A2.

  2002cited by this paper
• Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability*

  2002cited by this paper
• Cytosolic Phospholipase A 2 (cPLA 2 ) Regulation of Human Monocyte NADPH Oxidase Activity cPLA 2 AFFECTS TRANSLOCATION BUT NOT PHOSPHORYLATION OF p67 phox AND p47 phox

  2002cited by this paper
• Alzheimer's Disease Is a Synaptic Failure

  2002cited by this paper
• Abeta42-peptide assembly on lipid bilayers.

  2002cited by this paper
• Lipid rafts reconstituted in model membranes.

  2001cited by this paper
• Oxidative Damage Is the Earliest Event in Alzheimer Disease

  2001cited by this paper
• Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis and neurotoxicity.

  2001cited by this paper
• Bending Contributions to Hydration of Phospholipid and Block Copolymer Membranes: Unifying Correlations between Probe Fluorescence and Vesicle Thermoelasticity

  2001cited by this paper
• Cellular membrane composition defines A beta-lipid interactions.

  2001cited by this paper
• Physical Properties of Erythrocyte Ghosts That Determine Susceptibility to Secretory Phospholipase A2 *

  2001cited by this paper
• Essential Requirement of Cytosolic Phospholipase A2for Stimulation of NADPH Oxidase-associated Diaphorase Activity in Granulocyte-like Cells*

  2001cited by this paper
• Amyloid beta-peptide1-40 increases neuronal membrane fluidity: role of cholesterol and brain region.

  2001cited by this paper
• Cellular Membrane Composition Defines Aβ-Lipid Interactions*

  2001cited by this paper
• Cytosolic phospholipase A2 is required for the activation of the NADPH oxidase associated H+ channel in phagocyte-like cells.

  2000cited by this paper
• Cholesterol Modulates the Membrane- Disordering Effects of Beta-Amyloid Peptides in the Hippocampus: Specific Changes in Alzheimer’s Disease

  2000cited by this paper
• A correlation between lipid domain shape and binary phospholipid mixture composition in free standing bilayers: A two-photon fluorescence microscopy study.

  2000cited by this paper
• Preparation, stability, and in vitro performance of vesicles made with diblock copolymers.

  2000cited by this paper
• Fibrillar islet amyloid polypeptide differentially affects oxidative mechanisms and lipoprotein uptake in correlation with cytotoxicity in two insulin-producing cell lines.

  2000cited by this paper
• Correlation of beta-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes.

  2000cited by this paper
• The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.

  1999cited by this paper
• Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration

  1999cited by this paper
• Distribution and Fluidizing Action of Soluble and Aggregated Amyloid β-Peptide in Rat Synaptic Plasma Membranes*

  1999cited by this paper
• Regulation and inhibition of phospholipase A2.

  1999cited by this paper
• Two-photon fluorescence microscopy observation of shape changes at the phase transition in phospholipid giant unilamellar vesicles.

  1999cited by this paper
• Effects of beta-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain. High potencies of A beta 1-42 and A beta 1-43.

  1998cited by this paper
• Essential Requirement of Cytosolic Phospholipase A2for Activation of the Phagocyte NADPH Oxidase*

  1998cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• Effects of β-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain. High potencies of Aβ1-42 and Aβ1-43

  1998cited by this paper
• Mechanisms by which thionin induces susceptibility of S49 cell membranes to extracellular phospholipase A2.

  1997cited by this paper
• Amyloid β‐Peptides Increase Annular and Bulk Fluidity and Induce Lipid Peroxidation in Brain Synaptic Plasma Membranes

  1997cited by this paper
• Two-photon fluorescence microscopy of laurdan generalized polarization domains in model and natural membranes.

  1997cited by this paper
• Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity.

  1996cited by this paper
• Free Fatty Acids, Neutral Glycerides, and Phosphoglycerides in Transient Focal Cerebral Ischemia

  1995cited by this paper
• Evidence for an increase in water concentration in bilayers after oxidative damage of phospholipids induced by ionizing radiation.

  1994cited by this paper
• Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol.

  1994cited by this paper
• Apolipoprotein E and cholesterol affect neuronal calcium signalling: the possible relationship to beta-amyloid neurotoxicity.

  1994cited by this paper
• Diversity of group types, regulation, and function of phospholipase A2.

  1994cited by this paper
• MODULATION AND DYNAMICS OF PHASE PROPERTIES IN PHOSPHOLIPID MIXTURES DETECTED BY LAURDAN FLUORESCENCE *

  1993cited by this paper
• Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum.

  1993cited by this paper
• Membrane aging during cell growth ascertained by Laurdan generalized polarization.

  1992cited by this paper
• Directed establishment of rat brain cell lines with the phenotypic characteristics of type 1 astrocytes.

  1992cited by this paper
• beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

  1992cited by this paper
• Phase fluctuation in phospholipid membranes revealed by Laurdan fluorescence.

  1990cited by this paper
• Are disturbances in lipid-protein interactions by phospholipase-A2 a predisposing factor in affective illness?

  1989cited by this paper
• Differential inhibitory effects by phospholipase A2 on guanylate and adenylate cyclases of Tetrahymena plasma membranes.

  1982cited by this paper
• Arachidonic acid, bradykinin and phospholipase A2 modify both prolactin binding capacity and fluidity of mouse hepatic membranes.

  1981cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• BIOCHIMICA ET BIOPHYSICA ACTA

  year unknowncited by this paper

• Cytosolic phospholipase A2 links tau pathology to insulin signaling impairment in Alzheimer’s disease

  2025cites this paper
• Alzheimer's disease amyloid-β affects membrane structure and mechanical properties of human neural progenitors

  2025cites this paper
• Evidence for cPLA2 activation in Alzheimer’s Disease Synaptic Pathology

  2025cites this paper
• sn-Position-Resolved Quantification of Aminophospholipids by Isotopic N,N-Dimethyl Leucine Labeling and High-Resolution Ion Mobility Mass Spectrometry.

  2024cites this paper
• Metabolic profiling of Alzheimer's disease: Untargeted metabolomics analysis of plasma samples.

  2023cites this paper
• Increased Expression and Activity of Brain Cortical cPLA2 Due to Chronic Lipopolysaccharide Administration in Mouse Model of Familial Alzheimer’s Disease

  2022cites this paper
• Alteration of plasma metabolic profile and physical performance combined with metabolites is more sensitive to early screening for mild cognitive impairment

  2022influential citation
• Dynamic Role of Phospholipases A2 in Health and Diseases in the Central Nervous System

  2021cites this paper
• Evaluating membrane structure by Laurdan imaging: Disruption of lipid packing by oxidized lipids.

  2021cites this paper
• Lipids: biomarkers of healthy aging

  2021cites this paper
• The Impact of the hAPP695SW Transgene and Associated Amyloid-β Accumulation on Murine Hippocampal Biochemical Pathways

  2021cites this paper
• Plasma lipidomic biomarker analysis reveals distinct lipid changes in vascular dementia

  2020cites this paper
• Roles of microglial membranes in Alzheimer's disease.

  2020cites this paper
• UHPLC-QTOF/MS-based metabolomics investigation for the protective mechanism of Danshen in Alzheimer’s disease cell model induced by Aβ1–42

  2019cites this paper
• Metabolomics analysis of Xanthoceras sorbifolia husks protection of rats against Alzheimer's disease using liquid chromatography mass spectrometry.

  2019cites this paper
• Cytosolic Phospholipase A2 Facilitates Oligomeric Amyloid-β Peptide Association with Microglia via Regulation of Membrane-Cytoskeleton Connectivity

  2018cites this paper
• Molecular rotors report on changes in live cell plasma membrane microviscosity upon interaction with beta-amyloid aggregates.

  2018cites this paper
• The molecular behavior of a single β‐amyloid inside a dipalmitoylphosphatidylcholine bilayer at three different temperatures: An atomistic simulation study: Aβ interaction with DPPC: Atomistic simulation

  2017cites this paper
• Effects of breviscapine on amyloid beta 1-42 induced Alzheimer's disease mice: A HPLC-QTOF-MS based plasma metabonomics study.

  2017cites this paper
• Dietary arachidonic acid as a risk factor for age-associated neurodegenerative diseases: Potential mechanisms.

  2016cites this paper
• Arachidonic acid in Alzheimer's disease

  2016cites this paper
• Signaling pathways regulating neuron–glia interaction and their implications in Alzheimer's disease

  2016cites this paper
• Role of membrane biophysics in Alzheimer's–related cell pathways

  2015cites this paper
• The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment

  2015cites this paper
• Low concentrations of ethanol protect against synaptotoxicity induced by Aβ in hippocampal neurons.

  2015cites this paper
• Cellular Membrane Fluidity in Amyloid Precursor Protein Processing

  2014cites this paper
• Platelet-activating factor antagonists enhance intracellular degradation of amyloid-β42 in neurons via regulation of cholesterol ester hydrolases

  2014cites this paper
• Metabolic Dysfunction of Astrocyte: An Initiating Factor in Beta-amyloid Pathology?

  2013cites this paper
• Ca2+‐dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid β‐treated astrocytes and in a model of Alzheimer's disease

  2013cites this paper
• astrogliosis in oligomeric amyloid b-treated astrocytes and in a model of Alzheimer's disease

  2013cites this paper
• Oxidative Stress in Neurodegenerative Diseases and Ageing

  2012cites this paper
• Mechanism of Oxidative Stress in Neurodegeneration

  2012cites this paper
• Phospholipases A2 and neural membrane dynamics: implications for Alzheimer’s disease

  2011cites this paper
• From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry.

  2011cites this paper
• 4‐hydroxy‐2‐nonenal upregulates and phosphorylates cytosolic phospholipase A2 in cultured Ra2 microglial cells via MAPK pathways

  2011cites this paper
• Hydroxyapatite

  2011cites this paper
• ROLE OF A-RECEPTOR FOR ADVANCED GLYCATION NDPRODUCTS INTERACTION IN OXIDATIVE STRESS AND YTOSOLIC PHOSPHOLIPASE A 2 ACTIVATION IN ASTROCYTES AND CEREBRAL ENDOTHELIAL CELLS

  2011cites this paper
• Impacts of Membrane Biophysics in Alzheimer's Disease: From Amyloid Precursor Protein Processing to Aβ Peptide-Induced Membrane Changes

  2011cites this paper
• Membrane Biophysics and Mechanics in Alzheimer's Disease

  2010cites this paper
• Involvement of cytosolic phospholipase A(2), calcium independent phospholipase A(2) and plasmalogen selective phospholipase A(2) in neurodegenerative and neuropsychiatric conditions.

  2010cites this paper
• Nitric oxide: target for therapeutic strategies in Alzheimer's disease.

  2010cites this paper
• NOX Enzymes in the Central Nervous System: From Signaling to Disease

  2009cites this paper